Artist rendering depicting synthetic platelets operating alongside natural platelets in a blood vessel. The visualization highlights key physiological processes, including adhesion and aggregation, inflammatory signaling and immune response, as well as clot retraction and stabilization.
What is a Shelf-Stable Blood Analog System?
In both military and civilian settings, severe blood loss and the resulting lack of oxygen to tissues (ischemia) are leading causes of preventable death following traumatic injury. While traditional blood products save lives, the strict requirement for continuous cold storage, limited shelf life, and reliance on donor supply create significant logistical hurdles for far-forward units and austere environments.
To address this challenge, the Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) program aims to deliver a shelf-stable, blood analog system that can be manufactured at scale and rapidly advance toward regulatory authorization.
https://www.darpa.mil/research/programs/rapiid?utm_source=dvids&utm_medium=referral&utm_campaign=rapiid&utm_content=synthetic-platelet
| Date Taken: | 07.17.2026 |
| Date Posted: | 07.17.2026 15:32 |
| Photo ID: | 9817481 |
| VIRIN: | 260717-O-SB080-2897 |
| Resolution: | 3000x1668 |
| Size: | 1.28 MB |
| Location: | ARLINGTON, VIRGINIA, US |
| Web Views: | 2 |
| Downloads: | 0 |
This work, DARPA program: RAPIID - synthetic platelets [Image 5 of 5], by Alissa Eckert, identified by DVIDS, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.
No keywords found.
